Cough as an adverse effect on inhalation pharmaceutical products.

British Journal of Pharmacology
Rachel Yoon Kyung ChangHak-Kim Chan

Abstract

Cough is an adverse effect that may hinder the delivery of drugs into the lungs. Chemical or mechanical stimulants activate the transient receptor potential in some airway afferent nerves (C-fibres or A-fibres) to trigger cough. Types of inhaler device and drug, dose, excipients and formulation characteristics, including pH, tonicity, aerosol output and particle size may trigger cough by stimulating the cough receptors. Release of inflammatory mediators may increase the sensitivity of the cough receptors to stimulants. The cough-provoking effect of aerosols is enhanced by bronchoconstriction in diseased airways and reduces drug deposition in the target pulmonary regions. In this article, we review the factors by which inhalation products may cause cough.

References

Feb 1, 1978·The Journal of Clinical Investigation·R H StraussJ J Jaeger
Apr 1, 1977·Respiration Physiology·H M Coleridge, J C Coleridge
Jan 1, 1977·Respiration; International Review of Thoracic Diseases·W Y Chen, D J Horton
Jun 1, 1976·Journal of Applied Physiology·G C Smaldone, E H Bergofsky
Aug 1, 1992·The American Review of Respiratory Disease·B MidgrenC G Persson
Jun 1, 1990·Thorax·R W Fuller, D M Jackson
Jul 1, 1989·The American Review of Respiratory Disease·N B ChoudryN B Pride
Apr 1, 1985·Journal of Applied Physiology·R W FullerP J Barnes
Apr 1, 1988·Clinical Science·R H LowryT W Higenbottam
Feb 1, 1987·Chest·C Shim, M H Williams
Aug 1, 1985·Journal of Applied Physiology·G C Smaldone, M S Messina
Mar 1, 1969·Thorax·G M Sterling, J C Batten
Jan 1, 1980·British Journal of Pharmacology·C P AllottP W Marshall
Jul 1, 1995·The European Respiratory Journal·J G Widdicombe
Jan 1, 1994·Annual Review of Physiology·H M Coleridge, J C Coleridge
Oct 6, 1997·American Journal of Respiratory and Critical Care Medicine·S D AndersonA R Clark
Oct 6, 1997·The European Respiratory Journal·S E MartinN J Douglas
Jul 22, 1999·The European Respiratory Journal·E HoutmeyersM Decramer
Jan 5, 2000·American Journal of Respiratory and Critical Care Medicine·K A MooreD Weinreich
Aug 10, 2000·American Journal of Respiratory and Critical Care Medicine·A F BarkerJ Quan
Apr 24, 2001·American Journal of Respiratory and Critical Care Medicine·R J O'Brien, P P Nunn
Oct 27, 2001·British Journal of Clinical Pharmacology·A H MoriceR Thompson
Jun 27, 2002·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·P P H Le BrunH G M Heijerman
Oct 29, 2002·Lancet·Bert Brunekreef, Stephen T Holgate
Jun 10, 2003·Annals of the New York Academy of Sciences·Guy F JoosRomain A Pauwels
Nov 18, 2003·British Journal of Clinical Pharmacology·N R Labiris, M B Dolovich
Jan 6, 2004·Fundamental & Clinical Pharmacology·Jean-Christophe DubusUNKNOWN Réseau de Recherche Clinique en Pneumologie Pédiatrique
Mar 9, 2004·The Journal of Physiology·Brendan J CanningBradley J Undem
Jun 11, 2004·Chest·Heikki O KoskelaSandra D Anderson
Sep 11, 2004·The European Respiratory Journal·A H MoriceUNKNOWN ERS Task Force
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·E M WestermanH G M Heijerman
Dec 2, 2004·The European Respiratory Journal·J Hogg
Jan 20, 2006·The New England Journal of Medicine·Mark R ElkinsUNKNOWN National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group
Jun 6, 2006·The Journal of Allergy and Clinical Immunology·Roberto de MarcoUNKNOWN European Community Respiratory Health Survey Therapy Group
Aug 18, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Brendan J CanningNanako Mori
Nov 8, 2006·Annals of Internal Medicine·Lisa CegliaAnastassios G Pittas
Dec 23, 2006·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·E M WestermanH G M Heijerman

❮ Previous
Next ❯

Citations

Mar 12, 2021·Advanced Drug Delivery Reviews·Yajie ZhangRobert O Williams
Aug 29, 2021·Pharmaceutics·Waiting TaiPhilip Chi Lip Kwok

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Bulletin Européen De Physiopathologie Respiratoire
J C Pounsford
The Journal of Allergy and Clinical Immunology
U G LallooK F Chung
© 2021 Meta ULC. All rights reserved